Written by Klarity Editorial Team
Published: Jun 6, 2026

If you’re a psychiatrist or PMHNP wondering whether you can manage anxiety patients entirely through telehealth — including prescribing benzodiazepines, SSRIs, and other controlled substances — the short answer is yes, you can. But there’s more to the story, especially with federal telemedicine rules in flux and state regulations varying wildly.
Let me walk you through what’s actually allowed, what’s changed recently, and what this means for your practice.
Here’s the big news: You can still prescribe controlled substances for anxiety via telehealth without an initial in-person visit — at least through the end of 2026.
The Ryan Haight Act normally requires an in-person medical evaluation before prescribing Schedule II-V controlled substances. But COVID-era flexibilities suspended that requirement, and the DEA just extended these telemedicine rules through December 2026. This means you can initiate treatment with alprazolam, clonazepam, or even Schedule II stimulants (for comorbid ADHD) entirely through video visits.
Why does this matter? In 2024 alone, over 7 million controlled substance prescriptions were written via telemedicine under these flexibilities. Without the extension, millions of patients would have lost access to care overnight.
What’s coming: The DEA is working on permanent telemedicine prescribing regulations, expected in late 2026. These will likely introduce new safeguards — possibly a special telemedicine DEA registration or other requirements — but for now, you’re operating under the same rules that have been in place since 2020.
Bottom line: Until those new rules drop, you can conduct psychiatric evaluations via video, initiate medications for anxiety disorders, and manage follow-ups completely remotely. Just document appropriately, use secure HIPAA-compliant platforms, and check your state’s PDMP before prescribing controlled substances.
Federal law gives you the green light, but state regulations add layers you need to navigate.
New York is one of the most provider-friendly states. No special telehealth prescribing restrictions beyond federal law. You can manage anxiety entirely online, prescribing SSRIs, benzodiazepines, beta-blockers — whatever’s clinically indicated. The only requirement: check the state’s iSTOP PDMP before prescribing any controlled substance (New York has one of the strictest PDMP mandates in the country).
New York also has insurance parity laws, meaning private insurers must cover and reimburse telehealth mental health visits at the same rate as in-person. Medicare in NY follows federal rules (more on that below).
California similarly has no unique restrictions on telehealth prescribing. You can do a video evaluation and prescribe Schedule IV anxiolytics or any other anxiety medication. California’s telehealth parity law (AB 744, effective 2021) ensures private insurance pays equivalently for virtual visits. One note: California doesn’t participate in the Interstate Medical Licensure Compact (IMLC), so if you’re licensed elsewhere, you’ll need a full California license to treat CA patients via telehealth.
Illinois allows telehealth prescribing with no special barriers. You must check the Illinois PMP before prescribing controlled substances, but otherwise you’re practicing under the same standard of care as in-person. Illinois Medicaid and most private plans cover tele-mental health at parity rates.
Florida has an interesting rule: the state generally bans teleprescribing of Schedule II controlled substances — but there’s a specific exception for psychiatric treatment. If you’re treating a mental health condition like anxiety (or ADHD, depression, etc.), you can prescribe Schedule II medications via telehealth.
For anxiety specifically, benzodiazepines (Schedule IV) aren’t affected by this ban anyway, so you’re clear to prescribe them remotely. Florida also requires PDMP checks (E-FORCSE) before prescribing any controlled anxiolytic.
One catch: Florida offers an out-of-state telehealth provider registration that lets you treat Florida patients without full licensure — but if you only have that registration (not a full FL license), you cannot prescribe controlled substances remotely. You’d need to be fully licensed in Florida to prescribe benzos or other controlled anxiety meds.
Texas prohibits using telemedicine to treat chronic pain with controlled substances, but this doesn’t apply to anxiety treatment. You can prescribe benzodiazepines and other anxiolytics via telehealth as long as you’ve established a valid patient-provider relationship through live audio-visual consultation. Texas requires PDMP checks and has no telehealth-specific quantity limits for physicians (those limits apply to teledentistry, not psychiatry).
Texas is part of the IMLC, which can make multi-state licensing easier if you’re looking to expand your telehealth practice.
Pennsylvania doesn’t have a comprehensive state telehealth law, but providers follow federal rules and professional board guidance. You can initiate SSRIs or benzodiazepines via telehealth if clinically appropriate and well-documented. Many insurers in PA voluntarily reimburse telepsychiatry at parity, and state Medicaid covers tele-mental health fully.
Here’s something to watch: Medicare had planned to require an in-person visit within 6 months before continuing tele-mental health services (and annually thereafter). Congress has repeatedly delayed enforcement of this rule — most recently through September 2025, and likely extending into 2026.
As of February 2026, you can still treat Medicare patients for anxiety via telehealth without periodic in-person visits. But verify current Medicare policy, because if this rule eventually takes effect, it could impact pure-telehealth practices serving Medicare beneficiaries.
For psychiatrists (MD/DO), the answer is straightforward: you have full prescriptive authority in all 50 states. No supervision requirements, no collaborative agreements. You can evaluate, diagnose, and prescribe any anxiety medication — including controlled substances — independently.
For Psychiatric Mental Health Nurse Practitioners, it depends entirely on your state.
In states with Full Practice Authority, PMHNPs can do everything a psychiatrist can when it comes to prescribing anxiety medications.
New York granted full independence to NPs in 2022. No more written practice agreements, no required physician collaboration. A New York PMHNP can open their own practice, manage anxiety patients completely independently, and prescribe benzodiazepines or any other medication within their scope.
Other FPA states include Arizona, Oregon, Washington, and about 20 others. In these states, the only real difference between an MD and PMHNP is the professional title and minor reimbursement variations (more on that below).
California is mid-transition. Historically a restricted state (requiring physician-supervised ‘standardized procedures’), California’s AB 890 created a pathway to independence. As of January 2023, experienced NPs can practice without standardized procedures in group settings (103 NP status). Starting January 2026, those NPs can apply for full independent practice authority (104 NP status).
Until you achieve 104 status, you’re still operating under physician agreements. But for experienced PMHNPs, California is opening up significantly.
Texas remains one of the most restrictive states. PMHNPs must have a Prescriptive Authority Agreement with a Texas physician to prescribe anything. The physician doesn’t co-sign every script, but they must provide supervision with periodic chart reviews.
Texas also limits NP prescribing of Schedule II controlled substances to hospital-based settings, hospice, or terminally ill patients. You can prescribe benzodiazepines (Schedule IV) for anxiety if your delegating physician has authorized it, but you cannot prescribe stimulants for comorbid ADHD in outpatient settings.
Florida requires PMHNPs to practice under a written protocol with a physician. You can prescribe controlled substances if it’s outlined in your protocol, and there’s a specific carve-out: while most Florida NPs are limited to a 7-day supply of controlled substances, psychiatric NPs treating mental disorders are exempt from this restriction. You can prescribe more than 7 days of benzodiazepines or other psychiatric controlled substances.
Pennsylvania requires a collaborative agreement throughout your career (unless laws change). The collaborating physician must review a percentage of your charts and co-sign Schedule II prescriptions within 24 hours. For anxiety medications like benzodiazepines, you can prescribe them if your agreement permits, but the physician will review those cases.
Illinois has a middle path: new NPs need a collaborative agreement, but after 4,000 clinical hours and 250 CE hours, you can apply for Full Practice Authority. Even with FPA, Illinois requires a one-time physician attestation for prescribing benzodiazepines or Schedule II narcotics — essentially, a physician signs off that these are in your scope. After that, you’re independent.
If you’re a PMHNP in a restricted state, you can absolutely manage anxiety patients and prescribe medications — but you’ll need that physician relationship in place. This can affect your ability to join pure-telehealth platforms unless they provide collaborating physicians or operate in FPA states.
Understanding the economics matters, especially if you’re considering telehealth work.
Medicare pays psychiatrists fairly well for medication management:
If you’re providing brief therapy alongside medication management, add-on code 90833 (30 minutes of psychotherapy) adds about $81 to the E/M payment.
Medicare currently pays for telehealth visits at the same rate as in-person through at least mid-2025, likely extending through 2026. This parity makes telehealth financially viable — you’re not taking a pay cut to practice remotely.
If you’re billing under your own NPI as an NP, Medicare reimburses at 85% of the physician fee schedule. So that $95 med check becomes about $81. Some practices use ‘incident to’ billing to get 100% reimbursement, but this generally doesn’t work in telepsychiatry where you’re the primary provider.
Most private insurers follow a similar pattern — NPs get reimbursed at 85-90% of physician rates. Some states’ Medicaid programs pay NPs and MDs equally, but it varies.
Medicaid rates are significantly lower — often 50-60% of Medicare. A 90792 initial eval might pay around $85 instead of $202. A 99213 follow-up might be $40-50.
The trade-off: higher patient volume can offset lower per-visit rates, and many underserved populations rely on Medicaid. If you’re joining a telehealth platform serving Medicaid patients, understand the economics going in.
Private insurance typically pays 100-150% of Medicare rates, depending on the plan and your contracted rates. Many states have telehealth parity laws requiring insurers to cover and reimburse tele-mental health equivalently to in-person care. California, Illinois, New York, and others have these protections in place.
Texas doesn’t have a state-mandated parity law, but many insurers voluntarily pay equivalent rates for tele-mental health after seeing its effectiveness during COVID.
Let’s talk about something most articles gloss over: what it actually costs to get patients.
If you’re marketing a private practice independently — SEO, Google Ads, directory listings — here’s what you’re looking at:
SEO takes 6-12 months of consistent investment before generating meaningful patient flow. You need content, backlinks, technical optimization. Most solo providers don’t have the expertise or patience for this.
Google Ads for mental health keywords run $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+, and that’s after months of testing and optimization.
Directory listings like Psychology Today or Zocdoc charge monthly fees, and you’re competing with hundreds of other providers on the same page. Zocdoc charges $35-100+ per booking depending on specialty, plus monthly subscription fees.
When you factor in ALL costs — agency/consultant fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, failed campaigns — acquiring a qualified psychiatric patient costs $200-500+ if you’re doing it yourself.
Most providers starting out or scaling don’t have $3,000-5,000/month to gamble on marketing with uncertain results.
This is where telehealth platforms like Klarity make economic sense. Instead of spending thousands upfront on marketing, you pay a standard listing fee per new patient lead — only when someone actually books with you.
The value proposition:
Instead of gambling $3,000-5,000/month on marketing channels that might not work, you’re paying for guaranteed results. That’s predictable ROI instead of marketing roulette.
Can DIY marketing eventually be cost-effective? Absolutely — if you have the budget, expertise, and patience to play the long game. But for most providers, especially those starting out or wanting to scale without the marketing headaches, a platform that handles patient acquisition removes the risk entirely.
If you’re looking to treat anxiety patients via telehealth:
Verify your state’s specific rules on telehealth prescribing and PMHNP scope (if applicable). The regulations above are current as of February 2026, but always double-check with your state medical or nursing board.
Get credentialed with your state’s PDMP and understand the check requirements before prescribing controlled anxiolytics.
Stay updated on federal rules. The DEA’s permanent telemedicine prescribing regulations are expected in late 2026. These will replace the current temporary flexibilities.
Understand the economics. Know what Medicare, Medicaid, and private insurers pay in your state for psychiatric services, and factor that into your practice decisions.
Consider your marketing reality. If you’re building a practice from scratch, be honest about whether you have the time, budget, and expertise for DIY patient acquisition — or whether joining a platform that handles that piece makes more sense.
Telehealth has permanently changed how we deliver psychiatric care. The tools are here, the regulations mostly support it, and patient demand has never been higher. The question isn’t whether you can manage anxiety patients remotely — it’s whether you’re set up to do it efficiently and economically.
If you’re interested in joining a provider network that handles patient acquisition, credentialing, and platform infrastructure so you can focus on clinical care, explore Klarity’s provider opportunities. We work with psychiatrists and PMHNPs across multiple states, handling the business side so you can do what you do best: help patients get better.
Can psychiatrists prescribe benzodiazepines via telehealth?
Yes. As of February 2026, psychiatrists can prescribe Schedule IV benzodiazepines (alprazolam, clonazepam, lorazepam) via telehealth without an initial in-person visit, under extended federal telemedicine flexibilities running through December 2026. You must check your state’s PDMP before prescribing and follow standard prescribing protocols.
What’s the difference between PMHNP and psychiatrist prescribing authority for anxiety meds?
Psychiatrists (MD/DO) have full independent prescriptive authority in all 50 states. PMHNPs’ authority depends on state law — in Full Practice Authority states (like New York, Arizona), they can prescribe independently just like psychiatrists. In restricted states (like Texas, Pennsylvania), they need a collaborative agreement with a physician and may face additional limitations on controlled substance prescribing.
Do I need an in-person visit to prescribe anxiety medication via telehealth?
Not under current federal rules (through 2026). The Ryan Haight Act’s in-person requirement has been suspended. However, some states may have additional requirements, and Medicare has discussed (but repeatedly delayed) implementing an in-person visit requirement for ongoing tele-mental health services. Verify current rules for your specific payer mix.
How much does Medicare pay for psychiatric medication management visits?
Medicare 2026 rates: initial psychiatric evaluation (90792) pays ~$202; a 15-minute medication follow-up (99213) pays ~$95; a 25-minute visit (99214) pays ~$136. If you add psychotherapy (30-min add-on code 90833), that’s an additional ~$81. PMHNPs billing under their own NPI receive 85% of these rates.
Can PMHNPs prescribe benzodiazepines in Texas?
Yes, but only with physician authorization. Texas PMHNPs must have a Prescriptive Authority Agreement with a physician that explicitly permits prescribing Schedule IV controlled substances (which includes benzodiazepines). The physician provides oversight through periodic chart reviews. Texas does restrict NP prescribing of Schedule II substances to hospital-based settings, but benzos are Schedule IV.
What states allow PMHNPs to prescribe anxiety medications independently?
States with Full Practice Authority for NPs (allowing independent prescribing) include: New York, Arizona, Oregon, Washington, Alaska, Hawaii, Montana, Nevada, New Mexico, Colorado, Wyoming, North Dakota, South Dakota, Nebraska, Iowa, Minnesota, Wisconsin, Michigan, Maine, Vermont, New Hampshire, Connecticut, Rhode Island, Maryland, and DC. Some states like California and Illinois have pathways to independence after meeting experience requirements.
Do I have to check the PDMP every time I prescribe anxiety medication?
It depends on your state and the medication. For controlled substances (like benzodiazepines), most states mandate PDMP checks before initial prescribing and periodically thereafter (some require checks for every controlled prescription, others allow exemptions for established patients). Non-controlled anxiety medications (SSRIs, SNRIs, buspirone, hydroxyzine) typically don’t require PDMP checks. Check your state’s specific PDMP rules.
What happens to telehealth prescribing rules after 2026?
The DEA is expected to issue permanent telemedicine prescribing regulations in late 2026 to replace the temporary COVID-era flexibilities. These may include new requirements like a special telemedicine DEA registration or other safeguards, but the goal is to maintain reasonable access to care while preventing diversion and abuse. Stay tuned to DEA announcements and professional association updates.
U.S. Department of Health and Human Services. ‘HHS and DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ Press Release, January 2, 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Florida State Senate. Florida Statutes §456.47 – Telehealth and §464.012 – Certified Nurse Midwife and Advanced Practice Registered Nurse; Practice; Controlled Substances. 2024 Edition. https://www.flsenate.gov/laws/statutes/2022/456.47 and https://www.flsenate.gov/laws/statutes/2024/464.012
California Board of Registered Nursing. ‘AB 890 Implementation – Nurse Practitioner Practice.’ Updated 2024. https://rn.ca.gov/practice/ab890.shtml
Nurse Practitioners of New York. ‘Breaking News: NP Modernization Act Passes – Full Practice Authority for NYS NPs.’ April 9, 2022. https://npny.enpnetwork.com/nurse-practitioner-news/216175-breaking-news-np-modernization-act-passes
NursePractitionerLicense.com. ‘Limitations of Practice as a Nurse Practitioner in Illinois.’ Updated February 12, 2024. https://www.nursepractitionerlicense.com/nurse-practitioner-licensing-guides/limitations-of-practice-as-a-nurse-practitioner-in-illinois/
This content is current as of February 26, 2026. Regulations and reimbursement rates are subject to change. Always verify current rules with your state medical or nursing board and relevant federal agencies.
Find the right provider for your needs — select your state to find expert care near you.